Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Oct 31, 2025 | (FY)Jul 31, 2025 | (Q4)Jul 31, 2025 | (Q3)Apr 30, 2025 | (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 175.09%1.38M | -37.36%2.01M | 56.36%851.58K | -59.75%324.97K | -53.86%337.1K | -55.83%500.21K | -4.98%3.22M | -26.62%544.63K | -48.12%807.42K | 32.80%730.61K |
| Selling and administrative expenses | 198.26%1.29M | -21.11%1.87M | 78.01%819.47K | -32.26%312.5K | -55.72%304.49K | -43.13%431.05K | -7.27%2.37M | -27.45%460.36K | -58.23%461.3K | 67.01%687.69K |
| -Selling and marketing expense | 193.15%24K | -7.35%54.07K | 387.51%33.17K | -19.24%6.53K | -73.60%6.2K | -59.09%8.19K | -68.17%58.36K | -76.60%6.8K | -88.28%8.08K | -69.67%23.47K |
| -General and administrative expense | 198.36%1.26M | -21.46%1.81M | 73.36%786.3K | -32.49%305.97K | -55.09%298.29K | -42.70%422.86K | -2.56%2.31M | -25.09%453.55K | -56.23%453.22K | 98.64%664.22K |
| Other operating expenses | 30.66%90.36K | -82.74%146.36K | -61.89%32.12K | -96.40%12.47K | -24.01%32.61K | -81.53%69.16K | 2.09%847.74K | -21.72%84.27K | -23.39%346.12K | -68.99%42.92K |
| Operating profit | -175.09%-1.38M | 37.36%-2.01M | -56.36%-851.58K | 59.75%-324.97K | 53.86%-337.1K | 55.83%-500.21K | 4.98%-3.22M | 26.62%-544.63K | 48.12%-807.42K | -32.80%-730.61K |
| Net non-operating interest income (expenses) | 123.34%29.42K | -7.79%-462.59K | 88.41%-19.42K | -44.73%-119.36K | -131.22%-197.75K | -34.60%-126.06K | 10.14%-429.17K | -50.18%-167.52K | 15.81%-82.47K | 39.48%-85.53K |
| Non-operating interest income | --41.36K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Non-operating interest expense | -90.53%11.93K | 7.79%462.59K | -88.41%19.42K | 44.73%119.36K | 131.22%197.75K | 34.60%126.06K | -10.14%429.17K | 50.18%167.52K | -15.81%82.47K | -39.48%85.53K |
| Other net income (expenses) | -31.36%-2.79K | -1,097.30%-783.91K | -2,190.93%-318.6K | -10,556.72%-311.71K | -169.28%-151.48K | 98.60%-2.13K | -60.82%78.6K | -97.80%15.24K | -100.97%-2.93K | 128.40%218.65K |
| Gain on sale of security | -31.36%-2.79K | -105.43%-6.77K | -106.60%-998 | 96.83%-360 | -101.52%-3.29K | 97.77%-2.13K | -33.99%124.59K | -97.78%15.12K | -103.77%-11.34K | 128.05%216.28K |
| Special income (charges) | ---- | -781.44%-567.26K | -59,623.81%-100K | -778,925.00%-311.53K | -123,492.86%-155.73K | --0 | ---64.36K | --168 | --40 | ---126 |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --311.53K | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Other special charges | ---- | --155.73K | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Less:Write off | ---- | --0 | --0 | --0 | 123,492.86%155.73K | --0 | --64.36K | ---168 | ---40 | --126 |
| -Gain on sale of property,plant,equipment | ---- | ---411.53K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | ---- | -1,242.83%-209.88K | -453,227.08%-217.6K | -97.84%181 | 202.41%7.54K | ---- | 54.81%18.37K | -100.44%-48 | 167,580.00%8.37K | 141.24%2.49K |
| Income before tax | -114.73%-1.35M | 8.56%-3.26M | -70.70%-1.19M | 15.32%-756.03K | -14.87%-686.33K | 54.41%-628.39K | 2.59%-3.57M | -332.80%-696.91K | 34.03%-892.81K | 59.12%-597.49K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -114.73%-1.35M | 8.56%-3.26M | -70.70%-1.19M | 15.32%-756.03K | -14.87%-686.33K | 54.41%-628.39K | 2.59%-3.57M | -332.80%-696.91K | 34.03%-892.81K | 59.12%-597.49K |
| Net income continuous operations | -114.73%-1.35M | 8.56%-3.26M | -70.70%-1.19M | 15.32%-756.03K | -14.87%-686.33K | 54.41%-628.39K | 2.59%-3.57M | -332.80%-696.91K | 34.03%-892.81K | 59.12%-597.49K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -114.73%-1.35M | 8.56%-3.26M | -70.70%-1.19M | 15.32%-756.03K | -14.87%-686.33K | 54.41%-628.39K | 2.59%-3.57M | -332.80%-696.91K | 34.03%-892.81K | 59.12%-597.49K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -114.73%-1.35M | 8.56%-3.26M | -70.70%-1.19M | 15.32%-756.03K | -14.87%-686.33K | 54.41%-628.39K | 2.59%-3.57M | -332.80%-696.91K | 34.03%-892.81K | 59.12%-597.49K |
| Diluted earnings per share | 0.00%-0.01 | 37.50%-0.05 | 0.00%-0.01 | 50.00%-0.01 | 0.00%-0.01 | 66.67%-0.01 | 20.00%-0.08 | 0.00%-0.01 | 50.00%-0.02 | 50.00%-0.01 |
| Basic earnings per share | 0.00%-0.01 | 37.50%-0.05 | 0.00%-0.01 | 50.00%-0.01 | 0.00%-0.01 | 66.67%-0.01 | 20.00%-0.08 | 0.00%-0.01 | 50.00%-0.02 | 50.00%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.